albiglutide

Five advancements in diabetes treatment to watch
Five advancements in diabetes treatment to watchThe healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.
New once-weekly treatment for type 2 DMAlbiglutide injection is the newest GLP-1 approved for once-weekly dosing in patients with type II diabetes, to be used in addition to diet and exercise.
Once-weekly GLP-1 injectable approved for type 2 diabetesFDA has approved albiglutide (Tanzeum, GlaxoSmithKline), a once-weekly subcutaneous injectable for the treatment of adults with type 2 diabetes.
FDA approves once-weekly GLP-1 injectable for type 2 diabetesFDA approved albiglutide (Tanzeum, GlaxoSmithKline), a once-weekly subcutaneous injectable for the treatment of adults with type 2 diabetes. It helps to improve glycemic control, along with diet and exercise.